Cargando…

Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go

Heart failure is a clinically complex syndrome that results due to the failure of the ventricles to function as pump and oxygenate end organs. The repercussions of inadequate perfusion are seen in the form of sympathetic overactivation and third spacing, leading to clinical signs of increased blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Gajjela, Harini, Kela, Iljena, Kakarala, Chandra L, Hassan, Mohammad, Belavadi, Rishab, Gudigopuram, Sri Vallabh Reddy, Raguthu, Ciri C, Modi, Srimy, Sange, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751580/
https://www.ncbi.nlm.nih.gov/pubmed/35028235
http://dx.doi.org/10.7759/cureus.20359
Descripción
Sumario:Heart failure is a clinically complex syndrome that results due to the failure of the ventricles to function as pump and oxygenate end organs. The repercussions of inadequate perfusion are seen in the form of sympathetic overactivation and third spacing, leading to clinical signs of increased blood pressure, dyspnea, fatigue, palpitations, etc. This article provided a brief overview of the clinical syndrome of heart failure; its epidemiology, risk factors, symptoms, and staging; and the mechanisms involved in disease progression. This article also described several landmark trials in heart failure that tested the efficacy of first-line drugs such as beta-blockers, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and the latest drugs in the field of heart failure: angiotensin receptor neprilysin inhibitors. Most studies described in this article were guideline-setting trials that revolutionized the practice of medicine and cardiology.